— Know what they know.
Not Investment Advice

CGEM NASDAQ

Cullinan Therapeutics, Inc.
1W: -13.4% 1M: +1.0% 3M: +2.4% YTD: +38.1% 1Y: +77.0% 3Y: +53.1% 5Y: -49.5%
$13.84
-0.14 (-1.00%)
 
Weekly Expected Move ±10.4%
$12 $14 $16 $17 $19
NASDAQ · Healthcare · Medical - Pharmaceuticals · Alpha Radar Neutral · Power 42 · $850.6M mcap · 44M float · 1.96% daily turnover · Short 54% of daily vol
Last Earnings 2026-05-07
EPS
$-0.75
▲ Beat +10.3%
Revenue
$4M
Est (actual pending)
EPS Beat Streak: 3 quarters
Next Earnings 2026-08-06
EPS Estimate
$-0.81
Range: $-1.07 - $-0.28
Revenue Estimate
$4M
8 analysts

Estimate vs Actual

Earnings Surprise History

13/19
EPS Beats
0/19
Revenue Beats
68%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-21 quarter 2027-06-30 $-0.78 $-0.78 $— $—
2026-05-21 quarter 2026-06-30 $-0.80 $-0.81 ▼ 0.01 $3,666,667 $3,666,667
2026-05-21 quarter 2027-12-31 $-0.57 $-0.57 $52,400,000 $52,390,000
2026-05-21 quarter 2026-09-30 $-0.85 $-0.86 ▼ 0.01 $2,000,000 $2,000,000
2026-05-21 annual 2026-12-31 $-3.04 $-3.06 ▼ 0.02 $19,683,054 $19,683,054
2026-05-21 quarter 2026-12-31 $-0.61 $-0.61 $20,100,395 $20,100,395
2026-05-21 annual 2030-12-31 $-1.63 $-1.63 $228,552,750 $228,551,650
2026-05-21 quarter 2027-03-31 $-0.57 $-0.57 $15,000,000 $15,000,000
2026-05-21 annual 2027-12-31 $-2.41 $-2.43 ▼ 0.02 $47,709,462 $47,709,462
2026-05-21 quarter 2027-09-30 $-0.86 $-0.86 $2,800,000 $2,750,000
2026-05-21 annual 2029-12-31 $-2.90 $-2.90 $69,738,750 $69,734,250
2026-05-18 quarter 2026-09-30 $-0.85 $-0.85 $2,000,000 $2,000,000
2026-05-18 annual 2028-12-31 $-2.89 $-3.01 ▼ 0.12 $31,442,357 $31,442,357
2026-05-18 quarter 2026-12-31 $-0.59 $-0.61 ▼ 0.02 $20,100,395 $20,100,395
2026-05-18 quarter 2026-06-30 $-0.80 $-0.80 $3,666,667 $3,666,667
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms